Across the recent three months, 9 analysts have shared their insights on Clorox (NYSE:CLX), expressing a variety of opinions spanning from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

In the assessment of 12-month price targets, analysts unveil insights for Clorox, presenting an average target of $153.89, a high estimate of $170.00, and a low estimate of $136.00. This current average represents a 1.04% decrease from the previous average price target of $155.50.

Analyzing Analyst Ratings: A Detailed Breakdown

A comprehensive examination of how financial experts perceive Clorox is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Capture valuable insights into Clorox's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Clorox analyst ratings.

Discovering Clorox: A Closer Look

Breaking Down Clorox's Financial Performance

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Clorox displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 16.04%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Staples sector.

Net Margin: Clorox's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 4.67%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Clorox's ROE excels beyond industry benchmarks, reaching 1162.5%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Clorox's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 1.56%, the company may face hurdles in generating optimal returns from its assets.

Debt Management: Clorox's debt-to-equity ratio surpasses industry norms, standing at 59.04. This suggests the company carries a substantial amount of debt, posing potential financial challenges.

How Are Analyst Ratings Determined?

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.

This article was generated by Benzinga's automated content engine and reviewed by an editor.